Literature DB >> 16951917

Four novel and three recurrent mutations of the BTK gene and pathogenic effects of putative splice mutations.

Duangrurdee Wattanasirichaigoon1, Suwat Benjaponpitak2, Chonnamet Techasaensiri2, Wasu Kamchaisatian2, Pakit Vichyanond3, Sucheela Janwityanujit4, Lulin Choubtum5, Sayomporn Sirinavin2.   

Abstract

X-linked agammaglobulinemia is caused by mutations in the human BTK gene, leading to recurrent pyogenic infections. We describe four novel and three known BTK-mutations in seven patients from seven (six Thai and one Burmese) families. All but one were sporadic cases. Patients 1 and 2 had recurrent mutations in exon 10 (R288W) and exon 17 (R562W), respectively. Patient 3, a previously healthy individual who presented with pseudomonas sepsis with ecthyma gangrenosum had a known mutation in exon 17 (1749delT), leading to frameshift effect (F583fsX586). Patient 4 manifested with sepsis and concurrent acute appendicitis and pneumonia. He had a mutation, IVS8 + 1G > A, which led to an insertion of intron 8 into the transcripts. In Patient 5, a novel change in exon 7, c.588G > C, initially presumed Q196H, was found to cause a leaky splicing mutation, resulting in three distinct transcripts containing 17, 108, and 190 bp of the 5'-terminal of intron 7, which led to truncated peptides consisting of 203 and 211 amino acid residues (or Q196fsX204 and Q196fsX212, respectively). Patient 6 had a mutation in exon 14 (W421X), while patient 7 had a newly defined large deletion of exons 6-9. All of the mothers tested were mutation carriers. Transcript analysis in three mothers who were heterozygous for frameshift mutations revealed a minimal amount of aberrant transcripts, while their affected children had full expression of the mutant alleles, suggesting rapid degradation due to nonsense-mediated mRNA decay in the mothers. This is the first report of mutations of BTK from Thailand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951917     DOI: 10.1007/s10038-006-0052-y

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  22 in total

1.  Pseudomonas aeruginosa sepsis and ecthyma gangrenosum as initial manifestations of primary immunodeficiency.

Authors:  María Baro; Miguel Angel Marín; Jesús Ruiz-Contreras; Sira Fernandez de Miguel; Ignacio Sánchez-Díaz
Journal:  Eur J Pediatr       Date:  2003-12-20       Impact factor: 3.183

2.  A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia.

Authors:  Eduardo López-Granados; Rebeca Pérez de Diego; Antonio Ferreira Cerdán; Gumersindo Fontán Casariego; Maria Cruz García Rodríguez
Journal:  J Allergy Clin Immunol       Date:  2005-09       Impact factor: 10.793

3.  Kinase activity and XLA phenotypic variability.

Authors:  Rebeca Pérez de Diego; Eduardo López Granados; Antonio Ferreira Cerdán; Gumersindo Fontán Casariego; M Cruz García Rodríguez
Journal:  J Allergy Clin Immunol       Date:  2005-01       Impact factor: 10.793

4.  De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.

Authors:  Mao-Tsair Lin; Yin-Hsiu Chien; Shyh-Dar Shyur; Li-Hsin Huang; Yi-Chi Chiang; Da-Chin Wen; Pei-Hsuan Liang; Hwai-Chih Yang
Journal:  Ann Allergy Asthma Immunol       Date:  2006-05       Impact factor: 6.347

5.  Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.

Authors:  S R Tzeng; M T Pai; F D Lung; C W Wu; P P Roller; B Lei; C J Wei; S C Tu; S H Chen; W J Soong; J W Cheng
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

6.  X-linked agammaglobulinemia presenting as pseudomonas aeruginosa septicemia.

Authors:  T Zenone; G Souillet
Journal:  Scand J Infect Dis       Date:  1996

7.  Evaluation of the fragile X (FRAXA) syndrome with methylation-sensitive PCR.

Authors:  A Weinhäusel; O A Haas
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

8.  Epigenetic regulation of androgen receptor gene expression in human prostate cancers.

Authors:  T Nakayama; M Watanabe; H Suzuki; M Toyota; N Sekita; Y Hirokawa; A Mizokami; H Ito; R Yatani; T Shiraishi
Journal:  Lab Invest       Date:  2000-12       Impact factor: 5.662

9.  Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA).

Authors:  Marija Velickovic; Madhuri L Prasad; Susan A Weston; Elizabeth M Benson
Journal:  Hum Mutat       Date:  2004-04       Impact factor: 4.878

10.  Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.

Authors:  M Vihinen; L Nilsson; C I Smith
Journal:  Biochem Biophys Res Commun       Date:  1994-12-15       Impact factor: 3.575

View more
  1 in total

1.  Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center.

Authors:  P Benjasupattananan; T Simasathein; P Vichyanond; V Leungwedchakarn; N Visitsunthorn; P Pacharn; O Jirapongsananuruk
Journal:  J Clin Immunol       Date:  2009-01-28       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.